News

Since announcing their partnership in April 2025, AstraZeneca and Revna Biosciences have made significant strides in improving lung cancer care across Ghana, from early diagnosis to…
Read More...

Viridian Therapeutics, Inc. has announced a major collaboration and license agreement with Kissei Pharmaceutical Co., Ltd. to develop and commercialize two investigational therapies —…
Read More...

ViroCell Biologics, a specialist viral vector CDMO for cell and gene therapy clinical trials, has announced a strategic manufacturing collaboration with AvenCell Therapeutics, a…
Read More...

Madrigal Pharmaceuticals, Inc. has entered an exclusive global license agreement with CSPC Pharmaceutical Group Limited for SYH2086, a preclinical oral small molecule GLP-1 receptor…
Read More...

Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. have announced a strategic partnership to co-develop and commercialize a promising new treatment for…
Read More...

Sarepta Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has informed the company it may lift its voluntary pause on shipments of ELEVIDYS (delandistrogene…
Read More...

Boehringer Ingelheim and Re-Vana Therapeutics, a US- and UK-based developer of ocular drug delivery technologies, have announced a strategic collaboration and licensing agreement aimed…
Read More...

GSK plc has announced a major strategic collaboration with Hengrui Pharma, aimed at developing up to 12 innovative medicines across Respiratory, Immunology & Inflammation…
Read More...

Ascendis Pharma A/S announced that the U.S. Food & Drug Administration (FDA) has approved SKYTROFA (lonapegsomatropin-tcgd) for the treatment of adults with growth hormone…
Read More...

Gilead Sciences, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending…
Read More...

Novo Nordisk announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending an expanded label for Alhemo…
Read More...

Pfizer Inc. and BioNTech SE announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending…
Read More...

Pfizer Inc. has announced the completion of a global (excluding China) licensing agreement with Chinese biopharmaceutical company 3SBio Inc., securing exclusive rights to develop,…
Read More...

GSK plc has announced that the European Union has approved its drug Blenrep (belantamab mafodotin) in combination therapies for the treatment of adults with relapsed or refractory…
Read More...

Solid Biosciences Inc., a clinical-stage company focused on genetic medicines for neuromuscular and cardiac diseases, announced it has received Fast Track designation from the U.S. Food…
Read More...

Janssen-Cilag International NV, a Johnson & Johnson company, announced that the European Commission has approved a new indication for DARZALEX (daratumumab) subcutaneous (SC)…
Read More...

A new potential treatment for generalised myasthenia gravis (gMG), a rare and debilitating autoimmune neuromuscular disease, has shown promising results in a large international…
Read More...

Biotech company Kling Bio has announced a new collaboration and license option agreement with global pharmaceutical giant Sanofi aimed at accelerating the discovery of neutralizing…
Read More...

Sutro Biopharma, Inc., a company specializing in next-generation antibody drug conjugates (ADCs), has announced a new collaboration with the U.S. Food and Drug Administration (FDA) to…
Read More...

Sanofi has announced an agreement to acquire London-based biotechnology company Vicebio Ltd, expanding its presence in the respiratory vaccine space. The deal brings with it a promising…
Read More...